Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 13.10.2026 FEX.LN IE00B8X9NW27 1,369,134.00 USD 155,335,054.79  113.455  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 13.10.2026 FEXD.LN IE00BWTNMB87  444,951.00 USD  44,621,441.25  100.284  ...

NEW YORK--(BUSINESS WIRE)--The International Insurance Society (IIS) has announced the finalists for the 2026 RGA Leaders of Tomorrow award....

SAN MATEO, Calif.--(BUSINESS WIRE)--Category: Distribution Related...

BROOKLYN, N.Y.--(BUSINESS WIRE)--Sola, a modern payments platform serving businesses and software partners, and PAX Technology, Inc. (PAX), a global leader in electronic payment solutions, today announced a strategic partnership that makes PAX the preferred terminal platform for Sola's in-person acceptance business — and the launch of Sola Terminal, a certified Sola application that brings cloud-driven, card-present payments to PAX Android devices. Sola Terminal is built on Sola's cloud technol...

CHAILLÉ-SOUS-LES-ORMEAUX, France--(BUSINESS WIRE)--Regulatory News: Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector that designs and markets innovative cold produced, clinker-free cements, announces the signing of a partnership with Rougier & Fils, a company specializing in structural construction and civil engineering works, particularly for indu...

CHAILLÉ-SOUS-LES-ORMEAUX, France--(BUSINESS WIRE)--Regulatory News: Hoffmann Green Cement Technologies (ISIN : FR0013451044, Mnémo : ALHGR) (« Hoffmann Green Cement » ou la « Société »), acteur industriel engagé dans la décarbonation du secteur de la construction qui conçoit et commercialise des ciments innovants sans clinker, annonce la signature d’un partenariat avec Rougier & Fils, entreprise spécialisée dans les travaux de gros œuvre et de génie civil, notamment pour les bâtiments indus...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Euronext : MEDCL) annonce que pour des raisons opérationnelles, la publication de ses résultats semestriels (avril-septembre 2026), aura lieu le mercredi 9 décembre 2026, en remplacement de la date initialement prévue du mardi 8 décembre. À propos de Medincell Medincell est une société biopharmaceutique innovante en phase clinique et commerciale, qui développe et commercialise sous licence des traitements injectables à action pro...

SAN FRANCISCO--(BUSINESS WIRE)--Today DOSS, the AI-native operations platform for consumer goods, introduced the next generation of its products: Dynamic Apps, a rebuilt Product Suite of modules, and an evolution of its agent copilot Dossbot. The release is the culmination of four years of work to build truly adaptive software. It delivers a suite of best-in-class enterprise applications designed to allow for customization without sacrificing forward-compatibility, so companies can execute thei...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Euronext: MEDCL) announces that, for operational reasons, the publication of its half-year financial results (April 1st –September 30, 2026) has been rescheduled to Wednesday, December 9, 2026, instead of the originally scheduled date of Tuesday, December 8, 2026. About Medincell Medincell is a clinical- and commercial-stage innovation-driven biopharmaceutical company developing and licensing long-acting injectable treatments acr...